ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-10 11:21:30 ET
ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST
Company Participants
Nicole Riley
Ameet Mallik - CEO & Director
Mohamed Zaki - Chief Medical Officer
Jose Carmona - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call Transcript
ADC Therapeutics SA
NASDAQ: ADCT
ADCT Trading
-5.62% G/L:
$4.20 Last:
295,591 Volume:
$4.36 Open:
ADCT Latest News
March 10, 2026 07:30:00 am
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
ADCT Stock Data
$486,217,661
104,923,913
12.45%
40
N/A
Biotechnology & Life Sciences
Healthcare
CH
Epalinges
